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Background. The HIV epidemic has changed the aetiology of meningitis in sub-Saharan Africa, and frontline clinicians are 
faced with a variety of meningitic presentations. Doctors working in resource-limited settings have the challenge of appropriately 
selecting patients for lumbar puncture (LP), a potentially risky procedure that requires laboratory analysis. 
Methods. In a rural South African hospital, the practice of performing LPs was audited against local guidelines. Data were 
collected retrospectively between February and June 2013. Symptoms and signs of meningitis, HIV status, investigations 
performed prior to LP and cerebrospinal fluid (CSF) results were recorded. With the aim of determining statistically significant 
clinical predictors of meningitis, parameters were explored using univariate and multivariate logistic regression analyses.
Results. A total of 107 patients were included, of whom 43% had an abnormal CSF result. The majority (76%) of patients were 
HIV-positive (CD4+ cell count <200 cells/µl in 46%). Cryptococcal meningitis (CCM) was the most prevalent microbiological 
diagnosis, confirmed in 10 out of 12 patients. Of the non-microbiological diagnoses, lymphocytic predominance was the most 
common abnormality, present in 17 out of 33 patients. Confusion (p=0.011) was the most statistically significant predictor of an 
abnormal CSF result. Headache (p=0.355), fever (p=0.660) and photophobia (p=0.634) were not statistically predictive.
Conclusion. The high incidence of CCM correlates with previous data from sub-Saharan Africa. In populations with high HIV 
prevalence, the classic meningitic symptoms of headache, fever and photophobia, while common presenting symptoms, are 
significantly less predictive of a meningitis diagnosis than confusion.
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Meningitis contributes significantly to mortality 
in countries with high HIV prevalence.[1] 
Cryptococcal meningitis (CCM) has become a 
significant opportunistic infection, accounting 
for 12 - 44% of early mortality in HIV-infected 
cohorts in resource-limited countries.[2,3] It carries an estimated 
annual global mortality of 500 000, with a case fatality rate of 
35 - 65% in sub-Saharan Africa.[1,4] Lumbar puncture (LP) and 
cerebrospinal fluid (CSF) analysis remain the cornerstones of 
diagnosis. Clinicians must be efficient in targeting patients to 
undergo this time-consuming and potentially risky procedure. 
Furthermore, laboratory CSF analysis is a cost consideration in 
resource-limited settings.
Studies exploring the presentation of meningitis in 
populations with high HIV prevalence generally lack statistical 
analysis of clinical predictors of an abnormal CSF result. Studies 
that analyse presenting features of meningitis are generally 
only from cohorts of patients with confirmed meningitis, 
without comparison with similar cohorts with normal CSF 
results.[5,6] The accuracy of variables to predict abnormal CSF 
results is not possible without this comparison. In addition, in 
studies determining clinical presentation of meningitis, there 
is a lack of logistic regression analysis; confounding features 
are not removed.[5,6] There is therefore little evidence that 
demonstrates statistically significant predictors of a positive 
meningitis diagnosis in populations with high HIV prevalence. 
Consequently, clinicians working in this setting have a paucity 
of evidence to use when trying to select patients for LP 
appropriately. Given the dangers associated with LP and the 
potential cost implications of CSF analysis, such literature is 
essential for guiding frontline clinicians in resource-limited 
settings as to when to suspect meningitis and when an LP is 
justified. Alongside this, clinicians must be aware of the contra-
indications to LP and must make appropriate use of tests such 
as platelet count, clotting and imaging, where available, to 
ensure patient safety.
Objective
Our first objective was to improve departmental practice 
through auditing the practice of performing diagnostic LPs 
against local guidelines in a regional referral hospital serving 
a rural South African (SA) population. We established local 
meningitis aetiology by reviewing the results of CSF analysis. 
The key objective was to determine which clinical parameters 














Stanger Provincial Hospital is a regional centre located in Ilembe 
District, in rural KwaZulu-Natal, SA. It serves a population of 
approximately 700 000 and has 500 inpatient beds. Referrals are re-
ceived from 15 smaller hospitals and satellite clinics. HIV prevalence 
in Ilembe district is 35.4%, one of the highest district rates in SA.[7] The 
emergency department (ED) treats ~2 500 patients a month, of whom 
1 500 have a med ical rather than a surgical complaint. Patients present ing 
with suspected meningitis are seen in the ED, where an LP is perf ormed 
and CSF results are analysed, with referral to the Department of Inter nal 
Medicine where appro priate.
Data collection
Audit data were collected retrospectively between February and June 
2013. All patients undergoing diagnostic LPs in the ED, regardless of 
indication, were eligible for inclusion. Doctors working in the dep-
artment were asked to make a note of patients undergoing LP by 
documenting their hos pital number. The audit team then used a data 
collection tool to gather information from the patient’s notes, namely 
indication for LP, HIV status, presenting symptoms and signs, CD4+ 
cell count, platelet count, international normalised ratio (INR), whether a 
computed tomography (CT) head scan was performed before LP, and CSF 
result. As the data collection was primarily for audit purposes, identifying 
information such as name, age and sex was not recorded; unique study 
numbers were used to identify patients. If information from the med-
ical notes did not provide all the key informa tion for the data collection 
tool, the patient was excluded from the audit. When the audit period had 
finished, the results were summarised. 
Clinicians did not record every patient undergoing LP. While every 
patient coming through the department was recorded in the ED 
admissions book, admitting diagnoses were not always clear in terms 
of whether meningitis was likely or an LP was performed. Therefore 
determining the audit sample size as a total number of patients 
undergoing LP could not be done accurately.
Patient management was audited against the Stanger Provincial 
Hospital Department of Internal Medicine 2010 guidelines for 
diagnostic LPs. According to these, relative contraindications were 
coagulopathy (platelets <50 × 109/l and INR >1.2) or suspicion of raised 
intracranial pressure (Glasgow Coma Scale (GCS) <12, focal neurological 
signs or papilloedema on fundoscopy). In these circumstances, platelet 
and/or freeze-dried plasma infusion or head CT, respectively, are advised 
prior to LP.
CSF diagnostic criteria were obtained from a study based in Cape Town 
in which 4 971 LPs were evaluated, the largest study of diagnostic LPs in 
SA.[8] A positive diagnosis for meningitis was made either microbiologically 
with staining, antigen testing and culture, or, if these were negative, through 
abnormal protein, glucose or chloride levels. Microbiological CSF diag noses 
were defined as CCM (positive cryptococcal latex antigen test (CLAT) and/
or India ink stain) or bacterial meningitis (BM) (positive Gram stain and/
or culture). In this rural setting, samples are not consistently sent for 
tuberculosis (TB) culture, and therefore this outcome was omitted from 
the study. Abnormal biochemical and microscopic findings were classified 
as follows: lymphocytic (lymphocytes >6 × 106/l), pyogenic (neutrophils 
>2 × 106/l), mixed or normocellular with abnormal protein and/or glucose 
(protein >0.5 g/dl and/or glucose <1.5 mmol/l). Abnormal CSF was a binary 
variable, with a positive result defined as any of the above abnormalities in 
staining, culture and antigen testing, as well as raised protein (>0.5 g/dL), 
low glucose (<1.5 mmol/L) or low chloride (<110 mEq/L).
Data analysis
Statistical analysis included descriptive stat istics with proportions, medians 
and inter quartile ranges (IQRs) calculated for non-parametric data, 
and means and standard deviations presented for parametric data. 
Potential pre dictors of abnormal CSF were evaluated using univariate and 
multivariate logistic regression analyses, namely headache, confusion, 
terminal neck stiffness, photophobia, focal neurological signs, seizures, 
HIV status and CD4+ cell count. Odds ratios (ORs) were presented with 
95% confidence intervals (CIs) and a statistical significance cut-off of 
p≤0.05. 
Stata 10.0 software (StataCorp, Stata Statistical Software, release 10, 
2007) was used for the statistical analysis.
Ethical approval
As this project was an audit of departmental practice, we did not apply 
for formal ethics committee approval. Approval to undertake the audit 
was granted by the ED consultants and Head of Department. In terms 
of consent for the LP procedure, clinicians obtained and recorded 
informed consent from all patients, or a relative in cases where the 
patient lacked capacity (e.g. low GCS). In children aged between 16 and 
18 years old, consent was obtained from a parent/guardian of the child. 
Results
From February to June 2013, 107 patient cases were audited. An HIV 
test was refused by 15 out of 107 patients (14%); among those who 
consented to the test, 81 out of 92 (88%) were seropositive. Many HIV-
positive patients had significant immunosuppression, with 46% (n=37) 
having a CD4+ cell count below 200 cells/µl and 34% (n=28) below 100 
cells/µl.
The most common symptom was head ache, present in 76% (n=80) of 
patients. Approximately half (51%) described the headache as focal, and 
the median duration was 4 days (IQR 2 - 7). Neck stiffness was reported by 
56% (n=60), and 38% (n=41) reported photophobia. Seizures were recalled 
by 5.6% (n=6), and confusion was present in 41% (n=44) (Table 1).
Table 1. Patient characteristics*
Characteristic
HIV-positive, n (%) 81 (75.7)
HIV-negative, n (%) 11 (10.3)
HIV status unknown, n (%) 15 (14.0)
CD4+ (cells/µl), median (IQR) 285.5 (47 - 408)
Headache, n (%) 80 (76.0)
Photophobia, n (%) 41 (38.0)
Confusion, n (%) 44 (41.0)
Seizures, n (%) 6 (5.6)
Temperature, n (%) 34 (32.0)
Kernig’s or Brudzinski’s sign, n (%) 20 (19.0)
Terminal neck stiffness, n (%) 38 (36.0)
Focal neurology, n (%) 2 (2.1)
IQR = interquartile range.
*N=107












On examination, 32% (n=34) were pyrexial. 
Kernig’s or Brudzinski’s signs were present in 
19% (n=20) and terminal neck stiffness was felt 
in 36% (n=38). There were two cases with focal 
neurology and one case with papilloedema, 
who underwent an LP. Papilloedema was not 
examined for in 86% (n=92) of patients. Fifty-
nine per cent (n=63) had a GCS of 15, 26% 
(n=28) had a GCS of between 13 and 14, and 
8.4% (n=16) had a GCS of ≤12 (Table 2). Of 
patients with a GCS <12, three had a CT prior 
to LP and three did not. The indication for the 
LP was meningitis in 83% (n=89), seizures in 
6.2% (n=6) and psychosis in 11% (n=12).
Prior to LP, 89% (n=94) had platelets 
checked, and of these one patient had a 
significantly reduced count at 14 × 109/l (1%). 
Only 7.5% (n=8) of patients had their INR 
checked prior to LP and of these, three patients 
had a result of 1.3 - 1.4 units. Prior to LP, 6.5% 
(n=7) underwent a CT scan. Out of the 107 
patients, 42% (n=45) had an abnormal CSF 
result. Of these, 27% (n=12) had confirmed 
microbiological diagnoses – 10 CCM and 2 
BM. The remaining abnormal results were 
17 lymphocytic, 10 mixed, 2 pyo genic and 4 
normocellular with abnormal protein and/or 
glucose (Fig. 1).
Overall, polymorphs were >2 × 106/l in 18% 
(n=19) and the lymphocytes were >6 × 106/l 
in 29% (n=31). Chloride was <110 in 7.6% 
(n=8) of cases. CSF glucose was <1.5 mmol/l 
in 14% (n=15) and protein was >0.5 g/dl in 
33% (n=35). Gram staining revealed Gram-
positive diplococci (streptococcus pneumoniae 
on culture) in one case and Gram-positive cocci 
(failed to culture) in another case. India ink 
staining identified Cryptococcal neoformans in 
five patients, and all of these plus an additional 
four cases had a positive CLAT. (Fig. 2)
Potential clinical predictors of abnormal 
CSF results were evaluated using univariate 
and multivariate logistic regression analyses 
(Table 3). Seizures and papilloedema were 
excluded from these analyses, as numbers 
were too small for these variables. In the 
unadjusted analysis, none of the factors were 
significantly associated with abnormal CSF 
results. Terminal neck stiffness was almost 
statistically significant, with an OR of 2.17 
(95% CI 0.97 - 4.87), as was raised temperature 
with an OR of 2.15 (95% CI 0.94 - 4.93). In the 
multivariate analysis, terminal neck stiffness 
remained almost statistically significant with 
an OR of 2.52 (95% CI 0.96 - 6.66). Confused 
patients were found to be significantly more 
likely to have abnormal CSF, with an OR of 
4.91 (95% CI 1.45 - 16.67) and p=0.011.
Discussion
The primary objective of this study was to 
determine statistically significant clinical 
pre dictors of meningitis through logistic 
regression analysis. Previous research has 
generally lacked this analysis and therefore 
has failed to account for confounding factors. 
Unlike previous studies, which only analysed 
presenting features from a cohort of patients 
with abnormal CSF results, in our study 
patients were selected before LP, allowing for 
proper estimation of the accuracy of each 
variable predicting abnormal CSF results. 
The logistic regression analyses demonstrated 
confusion as a strong predictor, with an OR 
of 4.91 and p=0.011. Previous papers that 










CCM Bacterial Lymphocytic Pyogenic Mixed Abnormal protein/
glucose/chloride
n=10 (22%) n=2 (4%) n=17 (38%) n=10 (22%) n=2 (4%) n=4 (8%)
Fig. 1. Frequency of CSF results. (CSF = cerebrospinal fluid; CCM = cryptococcal meningitis.)












GCS = Glasgow Coma Scale.










meningitis have found headache and fever as 
the most common presenting features, with a 
lower incidence of confusion.[5,6] For example, 
one study from Zambia found headache or 
abnormal temperature present in 91% of their 
HIV-positive patients with CCM, but only 13% 
were confused.[6] Our study has highlighted 
that although headache and fever were 
common symptoms in patients presenting 
for LP, they lacked specificity in predicting 
meningitis, as they were often present in 
patients with a normal CSF result (headache 
OR 1.39, p=0.355; fever OR 1.24, p=0.660). 
An explanation for this lack of specificity is 
that patients with HIV are at increased risk of 
multiple pathologies, of which headache and 
fever are symptoms. For example, migraines 
are more common in HIV-positive patients.[9] 
Therefore, these symptoms lack specificity in 
predicting meningitis. Photophobia, another 
symptom classically associated with meningitis 
and common in patients presenting for LP, 
was not statistically significant in predicting 
meningitis (OR 1.06, p=0.634). These findings 
highlighted that men ingitis is difficult to pre -
dict in HIV-positive patients. Furthermore, 
the varied aetiology showed that the classic 
presentation of meningitis is unlikely, proven 
by the lack of statistical predictability of 
classic meningitis symptoms. The fact that the 
incidence of meningitis is high (42% in our 
cohort) reveals that clinicians should have a 
low threshold for undertaking LP when not 
contraindicated. In resource-limited settings, 
selecting patients with more specific features, 
such as confusion rather than headache, 
may allow for a higher identification rate of 
abnormal CSF results. More research is needed 
in similar populations of high HIV prevalence 
to validate these findings and support clini-
cians in their decision to undertake LP.
The audit compared the practice of per-
forming LPs with current hospital guidelines. 
The checking of platelets was thorough, 
with 89% of patients checked prior to LP. 
However, checking of the INR was poor, with 
only 7.5% checked; among those with an INR 
result, 37.5% of the results were >1.2 (hospital 
guidelines stated that these patients required 
freeze-dried plasma prior to LP). The aetiology 
of these clotting disorders is unknown but 
may be explained by comorbidities such as 
viral hepatitis. The lack of INR checking 
can be explained by the lack of suspicion 
of coagulopathy on admission. Warfarin pre-
scription and sepsis at presentation were rare, 
so iatrogenic or sepsis-induced coagulopathies 
were not suspected clinically. While there has 
not been any published research examining 
the risk of bleeding from LP in patients with 
coagulopathy, it is considered best practice to 
correct an INR of >1.4 prior to LP.[10] In one 
literature review, 47% of 21 published cases of 
spinal haematoma following LP occurred in 
patients with a coagulopathy.[11] Following these 
audit results, new departmental protocol was 
to perform an INR on all patients and correct 
abnormalities accordingly.
In this study, local guidelines stated that 
patients with a GCS of <12 required a head CT 
prior to LP, but a CT was performed on only 
50% of such patients, which shows that practice 
clearly falls short of local standards. However, 
the reasoning behind performing a CT prior to 
LP remains controversial. A CT may identify 
an alternative pathology such as a mass lesion 
or indications of raised intracranial pressure, 
which could contraindicate LP. However, 
a normal CT scan does not exclude raised 
intracranial pressure and the scanning of 
patients potentially delays LP and antibiotic 
administration.[12] Guidelines need to be 
set locally. Following presentation and 
discussion of these audit findings at 
a departmental meeting, it was decided 
to perform a CT on any patient with a 
fluctuating GCS or GCS <12 prior to LP. 
In this rural SA setting with high HIV 
prevalence, 42% of patients had abnormal 
CSF results. The Cape Town study had a 
similarly high incidence of abnormal results, 
at 35%.[8] Of the abnormal results, 27% 
had definitive microbiological diagnoses, 
compared with 47% in Cape Town. Of the 
Table 3. Univariate and multivariate analyses of potential predictors of 
abnormal CSF results
Unadjusted Adjusted
Potential predictors of abnormal 
CSF result OR CI (95%) OR CI (95%) p
HIV status 1.99 0.78 - 5.10 2.20 0.71 - 6.82 0.171
Headache 1.39 0.57 - 3.41 1.79 0.52 - 6.12 0.355
Headache ≥7 days 1.06 0.43 - 2.60 - - -
Photophobia 1.06 0.48 - 2.33 1.26 0.48 - 3.32 0.634
Kernig’s/Brudzinski’s sign 0.86 0.32 - 2.31 0.50 0.16 - 1.59 0.243
Terminal neck stiffness 2.17 0.97 - 4.87 2.52 0.96 - 6.66 0.062
Confusion 1.63 0.75 - 3.54 4.91 1.45 - 16.67 0.011
GCS 0.81 0.62 - 1.06 0.84 0.64 - 1.11 0.229
Fever 2.15 0.94 - 4.93 1.25 0.46 - 3.35 0.660
CD4+ (cells/µl) ≤100 1.61 0.57 - 4.56 0.84 0.26 - 2.76 0.779



























































Fig. 2. Percentage of patients with abnormal CSF. (CSF = cerebrospinal fluid; CLAT = cryptococcal latex 
antigen test.)












positive microbiological diagnoses, 83% cultures grew Cryptococcus 
neoformans and 17% pyogenic bacteria (BM), in contrast to 63% and 
8%, respectively, in Cape Town.[8] We did not have culture results 
for tuberculous meningitis (TBM), for which the Cape Town figure 
was 28%.[8] Recent studies from other high HIV prevalence locations 
in Africa have found similar high rates of CCM; it is now the most 
prevalent cause of meningitis in sub-Saharan Africa (25 - 47%).[1]
As TB CSF culture was excluded from this study, direct comparisons 
could not be made with regard to TBM and total microbiological 
diagnoses – this was a limitation as discussed below. However, the 
high levels of lymphocytic predominance in the non-microbiological 
diagnoses almost certainly correlated with high levels of TBM, in the 
context of high HIV prevalence.[11] 
Limitations
A key limitation of this study was the lack of TB culture results due 
to the lack of TB culturing facilities at Stanger Provincial Hospital. TB 
meningitis is a significant cause of mortality in cohorts with high HIV 
prevalence and has a variety of initial CSF findings.[13] The high levels of 
lymphocytic predominance and raised protein would fit with high levels 
of TBM.[13] Therefore, our results almost certainly underestimated the 
prevalence of TBM in our population. While this clearly affected our 
aetiological results, it had less of an impact on our statistical analysis as 
this was based on a positive CSF diagnosis in general (microbiological 
and non-microbiological results), rather than specific microbiological 
diagnoses. The lack of TB culturing at a facility is a common issue in the 
developing world – clinicians often have only their clinical impression 
plus initial CSF results with which to make diagnostic decisions. Even 
if culturing facilities are available, TB culture often takes some time to 
grow. This is why the outcome from this study is relevant for clinicians 
working in this setting – it demonstrates which presenting features are 
predictive of the CSF results on the basis of which diagnoses are made.
Another limitation was the quality control in the clinicians’ 
documentation. Because this was a retrospective departmental audit, 
we could not ensure that all information recorded in the notes was 
consistent. The GCS was the most common area of subjectivity, for 
example several patients had GCS 15 recorded in the notes while 
they were identified as confused in the history (therefore GCS ≤14). 
However, in general, the major presenting features audited were 
objective. One area inconsistently recorded was antiretroviral therapy 
use, which therefore had to be excluded from the results. This would 
have been a valuable set of results, comparing the presentation and 
aetiology of meningitis in HIV-positive patients currently on or not 
on ART.
Conclusion
This audit demonstrated that LP practice in the ED did not adhere to 
local guidelines in certain areas. Following presentation of the results 
and discussion at a departmental meeting, it was agreed that prior to 
LP, an INR should be measured routinely, and a head CT should be 
performed on any patient with fluctuating GCS or GCS <12. The high 
prevalence of CCM from our data was consistent with other studies, 
which demonstrated that cryptococcosis has become the leading cause 
of adult meningitis in sub-Saharan Africa.[1] While there were limitations 
to the project, the data analysis has demonstrated some valuable 
findings. Current literature analysing the presentation of meningitis in 
cohorts with high HIV prevalence generally fails to compare normal 
with abnormal CSF groups and lacks logistic regression analysis. Our 
statistical analysis demonstrated confusion to be a significant predictor 
of an abnormal CSF result. While headache, fever and photophobia were 
common presenting symptoms, they were not statistically significant 
predictors of meningitis. Clinicians working in populations with high 
HIV prevalence need to have a broad differential diagnosis for patients 
presenting with headache and have a low threshold for performing LP 
or empirically treating meningitis in confused patients.
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